Publicaciones en las que colabora con JUAN JOSÉ TORRADO DURÁN (21)

2023

  1. Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum

    Antibiotics, Vol. 12, Núm. 2

2022

  1. In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration

    Pharmaceutics, Vol. 14, Núm. 12

  2. Leishmania infantum infection does not affect the main composition of the intestinal microbiome of the Syrian hamster

    Parasites and Vectors, Vol. 15, Núm. 1

2008

  1. Effects of hydroxypropyl-β-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers

    Pharmazie, Vol. 63, Núm. 7, pp. 511-513

2004

  1. Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration

    Biomaterials, Vol. 25, Núm. 4, pp. 707-714

  2. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs

    International Journal of Pharmaceutics, Vol. 272, Núm. 1-2, pp. 29-36

2003

  1. Effect of two formulations of benzimidazole carbamates on the viability of cysts of Echinococcus granulosus in vivo

    Parasite, Vol. 10, Núm. 4, pp. 371-373

2001

  1. Micromeritic and packing properties of diclofenac pellets and effects of some formulation variables

    Drug Development and Industrial Pharmacy, Vol. 27, Núm. 8, pp. 847-855

1997

  1. Administración intranasal de fármacos (II): absorción y deposición nasal de fármacos

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 6, pp. 69-77

  2. Administración intranasalde fármacos (I): características anatómicas y fisiológicas de la nariz

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 5, pp. 111-117

  3. Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of trichinella spiralis in mice

    International Journal for Parasitology, Vol. 27, Núm. 7, pp. 781-785

1996

  1. Effect of drug release rate on bioavailability of different aspirin tablets

    International Journal of Pharmaceutics, Vol. 133, Núm. 1-2, pp. 65-70

  2. Formulation parameters of albendazole solution

    International Journal of Pharmaceutics, Vol. 140, Núm. 1, pp. 45-50

  3. Preparation, dissolution and characterization of albendazole solid dispersions

    International Journal of Pharmaceutics, Vol. 140, Núm. 2, pp. 247-250

1995

  1. Influence of drug location on the release of coated pellets

    Pharmazie, Vol. 50, Núm. 12, pp. 830-831

1994

  1. In vitro drug release of flubendazole solid dispersions

    Proceedings of the Controlled Release Society

1993

  1. Compression behavior of acetylsalicylic acid pellets

    Drug Development and Industrial Pharmacy, Vol. 19, Núm. 12, pp. 1369-1377

  2. In vitro drug release of albendazole solid dispersions

    Proceedings of the Controlled Release Society

  3. MICROENCAPSULACION DE VITAMINA A

    Anales de la Real Academia de Farmacia, Vol. 59, Núm. 1, pp. 109-119

1992

  1. Topical application of albumin microspheres containing vitamin A drug release and availability

    International Journal of Pharmaceutics, Vol. 86, Núm. 2-3, pp. 147-152